+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Parkinson's Disease - Pipeline Review, H1 2020

  • ID: 5024731
  • Drug Pipelines
  • April 2020
  • Region: Global
  • 1201 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • 1st Bio Therapeutics Inc
  • Avicanna Inc
  • CuraSen Therapeutics Inc
  • Inexia Ltd
  • Neuroene Therapeutics LLC
  • reMYND NV
  • MORE
Parkinson's Disease - Pipeline Review, H1 2020

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease - Pipeline Review, H1 2020, provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape.

Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of dopaminergic neurons in substantia nigra. Symptoms generally develop slowly over years. People with PD experience dyskinesia, dystonia, tremor, stiffness and impaired locomotory functions. Risk factors include age, genetic factors, environmental factors and gender. Treatment options include anticholinergics, COMT inhibitors and dopamine agonists.

Report Highlights

This Pharmaceutical and Healthcare latest pipeline guide Parkinson's Disease - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Parkinson's Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 10, 47, 58, 4, 212, 90 and 9 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 1, 51 and 15 molecules, respectively.

Parkinson's Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Parkinson's Disease (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Parkinson's Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Parkinson's Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Parkinson's Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Parkinson's Disease (Central Nervous System)
Reasons to Buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Parkinson's Disease (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Parkinson's Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 1st Bio Therapeutics Inc
  • Avicanna Inc
  • CuraSen Therapeutics Inc
  • Inexia Ltd
  • Neuroene Therapeutics LLC
  • reMYND NV
  • MORE
  • Introduction
  • Parkinson's Disease - Overview
  • Parkinson's Disease - Therapeutics Development
  • Parkinson's Disease - Therapeutics Assessment
  • Parkinson's Disease - Companies Involved in Therapeutics Development
  • Parkinson's Disease - Drug Profiles
  • Parkinson's Disease - Dormant Projects
  • Parkinson's Disease - Discontinued Products
  • Parkinson's Disease - Product Development Milestones
  • Appendix
List of Tables
  • Number of Products under Development for Parkinson's Disease, H1 2020
  • Number of Products under Development by Companies, H1 2020
  • Number of Products under Development by Universities/Institutes, H1 2020
  • Number of Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
  • Number of Products under Development by Universities/Institutes, H1 2020 (Contd..2), H1 2020
  • Number of Products under Development by Universities/Institutes, H1 2020 (Contd..3), H1 2020
  • Products under Development by Companies, H1 2020
  • Products under Development by Universities/Institutes, H1 2020
  • Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
  • Products under Development by Universities/Institutes, H1 2020 (Contd..2), H1 2020
  • Products under Development by Universities/Institutes, H1 2020 (Contd..3), H1 2020
  • Number of Products by Stage and Target, H1 2020
  • Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020
  • Number of Products by Stage and Target, H1 2020 (Contd..2), H1 2020
  • Number of Products by Stage and Target, H1 2020 (Contd..3), H1 2020
  • Number of Products by Stage and Target, H1 2020 (Contd..4), H1 2020
  • Number of Products by Stage and Target, H1 2020 (Contd..5), H1 2020
  • Number of Products by Stage and Target, H1 2020 (Contd..6), H1 2020
  • Number of Products by Stage and Target, H1 2020 (Contd..7), H1 2020
List of Figures
  • Number of Products under Development for Parkinson's Disease, H1 2020
  • Number of Products under Development by Companies, H1 2020
  • Number of Products under Development by Universities/Institutes, H1 2020
  • Number of Products by Top 10 Targets, H1 2020
  • Number of Products by Stage and Top 10 Targets, H1 2020
  • Number of Products by Top 10 Mechanism of Actions, H1 2020
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
  • Number of Products by Top 10 Routes of Administration, H1 2020
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2020
  • Number of Products by Top 10 Molecule Types, H1 2020
  • Number of Products by Stage and Top 10 Molecule Types, H1 2020
Note: Product cover images may vary from those shown
3 of 3
  • 1st Bio Therapeutics Inc
  • 4D Pharma Plc
  • Abaxy Sprl
  • AbbVie Inc
  • Abivax SA
  • ABL Bio Inc
  • AC Immune SA
  • Acelot Inc
  • AcuraStem Inc
  • Addex Therapeutics Ltd
  • Affichem SA
  • AFFiRiS AG
  • AgoneX Biopharmaceuticals Inc
  • Alan Laboratories Inc
  • Alector Inc
  • Alectos Therapeutics
  • Alexza Pharmaceuticals Inc
  • Alkahest Inc
  • Alkermes Plc
  • Allife Medical Science and Technology Co Ltd
  • AlphaCognition Inc
  • Alsonex Pty Ltd
  • Alterity Therapeutics Ltd
  • Amabiotics SAS
  • Amathus Therapeutics Inc
  • Amneal Pharmaceuticals Inc
  • Anavex Life Sciences Corp
  • Anida Pharma Inc
  • Annovis Bio Inc
  • Antoxis Ltd
  • Aoxing Pharmaceutical Company Inc
  • Apollo Therapeutics LLC
  • Appello Pharmaceuticals Inc
  • Aprinoia Therapeutics Inc
  • AptaBio Therapeutics Inc
  • Aptamer Sciences Inc
  • Araclon Biotech SL
  • Aranda Pharma Ltd
  • AriBio
  • ArmaGen Inc
  • Arrien Pharmaceuticals LLC
  • Arvinas Inc
  • Asdera LLC
  • Asklepios BioPharmaceutical Inc
  • Aspen Neuroscience Inc
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Athersys Inc
  • Athira Pharma Inc
  • Auritec Pharmaceuticals Inc
  • Avicanna Inc
  • Axial Biotherapeutics Inc
  • Axovant Gene Therapies Ltd
  • AZTherapies Inc
  • Azymus Therapeutics Inc
  • B&A Therapeutics
  • BCWorld Pharm Co Ltd
  • Belrose Pharma Inc
  • Berg LLC
  • Better Life Pharmaceuticals Inc
  • Bial - Portela & Ca SA
  • Bio-Modeling Systems SAS
  • Bio-Pharm Solutions Co Ltd
  • Bioasis Technologies Inc
  • Biogen Inc
  • BlueRock Therapeutics
  • BrainStorm Cell Therapeutics Inc
  • Bristol-Myers Squibb Co
  • C4X Discovery Holdings Plc
  • Calico LLC
  • Califia Bio Inc
  • Cantabio Pharmaceuticals Inc
  • Canvax Biotech SL
  • Capo Therapeutics Inc
  • Carmot Therapeutics Inc
  • Carna Biosciences Inc
  • Cavion LLC
  • CavoGene LifeSciences
  • Celavie Biosciences LLC
  • CellCure
  • Cellivery Therapeutics Inc
  • Cellix Bio Pvt Ltd
  • Cerecin Inc
  • Cerecor Inc
  • CereSpir Inc
  • Cerevance Inc
  • Cerevel Therapeutics LLC
  • CHA Biotech Co Ltd
  • Chase Therapeutics Corp
  • Chiesi Farmaceutici SpA
  • Chipscreen Biosciences Ltd
  • CholesteniX Ltd
  • Chongqing Pharmaceutical Research Institute Co Ltd
  • Ci Therapeutics
  • Clayton Biotechnologies Inc
  • Clene Nanomedicine Inc
  • Clevexel Pharma SAS
  • Cogentis Therapeutics Inc
  • Collaborative Medicinal Development LLC
  • Contera Pharma ApS
  • Copernicus Therapeutics Inc
  • Corium, Inc.
  • Crossject SA
  • CuraSen Therapeutics Inc
  • Curemark LLC
  • CuroNZ Ltd
  • Curyx Bio Inc
  • Cypralis Ltd
  • Dadang & BIO Co Ltd
  • DanPET AB
  • Declion Pharmaceuticals Inc
  • DegenRx BV
  • Denali Therapeutics Inc
  • DermaXon LLC
  • Diffusion Pharmaceuticals Inc
  • Dina Pharmaceuticals Inc
  • Dizlin Medical Design AB
  • Domain Therapeutics SA
  • DongKoo Bio & Pharma Co Ltd
  • E-scape Bio Inc
  • Easywell Biomedical Inc
  • Eisai Co Ltd
  • Eli Lilly and Co
  • Emerald Health Sciences Inc
  • Emerald Organic Products Inc
  • Energenesis Biomedical Co Ltd
  • Evgen Pharma Plc
  • Fabre-Kramer Pharmaceuticals Inc
  • Fortuna Fix Inc
  • Fulcrum Therapeutics Inc
  • GB Sciences Inc
  • Generoath Co Ltd
  • Genervon Biopharmaceuticals LLC
  • GenKyoTex SA
  • Genmab AS
  • Genzyme Corp
  • Gismo Therapeutics Inc
  • Global BioLife Inc Ltd
  • GNT Pharma Co Ltd
  • Grespo AB
  • GT Gain Therapeutics SA
  • Guangzhou Magpie Pharmaceutical Co Ltd
  • H. Lundbeck AS
  • Hebei Newtherapy BIo-Pharma Technology Co Ltd
  • Herantis Pharma Plc
  • HitGen LTD
  • Hong Kong WD Pharmaceutical Co Ltd
  • Hope Biosciences LLC
  • Icagen Inc
  • ICB International Inc
  • Icure Pharmaceutical Inc
  • Imago Pharmaceuticals Inc
  • Immune Modulation Inc
  • Immungenetics AG
  • Impel NeuroPharma Inc
  • Inexia Ltd
  • Inflazome Ltd
  • Inhibikase Therapeutics Inc
  • InnoMedica Holding AG
  • Intec Pharma Ltd
  • International Stem Cell Corp
  • Intra-Cellular Therapies Inc
  • Invisio Ltd
  • Io Therapeutics Inc
  • Ionis Pharmaceuticals Inc
  • IRLAB Therapeutics AB
  • Jazz Pharmaceuticals Plc
  • Jeil Pharmaceutical Co Ltd
  • Junaxo Inc
  • Kainos Medicine Inc
  • Kariya Pharmaceuticals IVS
  • Kashiv BioSciences LLC
  • Keapstone Therapeutics Ltd
  • Kissei Pharmaceutical Co Ltd
  • Kyowa Kirin Co Ltd
  • Lauren Sciences LLC
  • Lead Discovery Center GmbH
  • Living Cell Technologies Ltd
  • Longevity Biotech Inc
  • Luye Pharma Group Ltd
  • Lysosomal Therapeutics Inc
  • Macrobian Biotech BV
  • Mavalon Therapeutics Ltd
  • MD Healthcare Inc
  • Med-Life Discoveries LP
  • MedGenesis Therapeutix Inc
  • MeiraGTx Holdings Plc
  • Merck & Co Inc
  • Meta-IQ ApS
  • Metabolic Solutions Development Company LLC
  • MetiMedi Pharmaceuticals Co Ltd
  • MetVital Inc
  • MimeTech Srl
  • Minerva Neurosciences Inc
  • Mission Therapeutics Ltd
  • Mitochon Pharmaceuticals Inc
  • Mitoconix Bio Ltd
  • MitoDys Therapeutics Ltd
  • Mitokinin LLC
  • Mitsubishi Tanabe Pharma Corp
  • Modag GmbH
  • Montisera Ltd
  • Motac Neuroscience Ltd
  • Neonc Technologies Inc
  • Netherlands Translational Research Center BV
  • NeuBase Therapeutics Inc
  • NeuExcell Therapeutics Inc
  • Neuracle Science Co Ltd
  • Neuraly Inc
  • Neuren Pharmaceuticals Ltd
  • Neuro Vigor LLC
  • Neurocea Pharmaceuticals
  • Neurochlore
  • Neurodon LLC
  • Neuroene Therapeutics LLC
  • NeuroGeneration Inc
  • Neurona Therapeutics Inc
  • NeuroNascent Inc
  • NeuroPn Therapeutics LLC
  • Neuropore Therapies Inc
  • Neurotrope Bioscience Inc
  • New Amsterdam Sciences Inc
  • New Biotic Inc
  • New World Laboratories Inc
  • Newron Pharmaceuticals SpA
  • Nitrome Biosciences Inc
  • nLife Therapeutics SL
  • NLS Pharma Group
  • Novartis AG
  • Novo Nordisk AS
  • NTZ Lab Ltd
  • NutriBand Inc
  • Omeros Corp
  • Oncodesign SA
  • Orphazyme A/S
  • Orpheris Inc
  • Oryzon Genomics SA
  • Oxyrane Belgium NV
  • Parkure Ltd
  • Peptron Inc
  • Pfizer Inc
  • Pharma Two B Ltd
  • PharmatrophiX Inc
  • Pharmicell Co Ltd
  • Phoenix Biotechnology Inc
  • Phoenix Life Sciences International Ltd
  • PK Biosciences Corp
  • Plex Pharmaceuticals Inc
  • Polaryx Therapeutics Inc
  • PolyCore Therapeutics LLC
  • Prevail Therapeutics Inc
  • Priavoid GmbH
  • Primary Peptides Inc
  • Proclara Biosciences Inc
  • ProMIS Neurosciences Inc
  • Promius Pharma LLC
  • Prothena Corp Plc
  • Prous Institute for Biomedical Research SA
  • Psy Therapeutics Inc
  • PTC Therapeutics Inc
  • reMYND NV
  • Renown Pharmaceuticals Pvt Ltd
  • resTORbio Inc
  • Retrotope Inc
  • Revalesio Corp
  • Rich Pharmaceuticals Inc
  • Rionis LLC
  • Sage Therapeutics Inc
  • SalubRx Therapeutics Inc
  • SanBio Inc
  • Sandoz International GmbH
  • Saniona AB
  • Sanofi
  • Seelos Therapeutics, Inc.
  • Seneb BioSciences Inc
  • Sengenics International Pte Ltd
  • Serina Therapeutics Inc
  • Shanghai Angecon Biotechnology Corp
  • Shenox Pharmaceuticals LLC
  • Shift Bioscience Ltd
  • SignPath Pharma Inc
  • Sinfonia Biotherapeutics Inc
  • Sorrento Therapeutics Inc
  • SparkBioPharma Inc
  • STATegics Inc
  • Sumitomo Dainippon Pharma Co Ltd
  • Sun Pharma Advanced Research Company Ltd
  • Sunovion Pharmaceuticals Inc
  • Suven Life Sciences Ltd
  • Synthonics Inc
  • Takeda Pharmaceutical Co Ltd
  • Tarus Therapeutics Inc
  • TauRx Therapeutics Ltd
  • Techfields Pharma Co Ltd
  • TechnoPhage SA
  • Teikoku Pharma USA Inc
  • Tranquis Therapeutics Inc
  • TreeFrog Therapeutics SAS
  • Treventis Corp
  • Trucode Gene Repair Inc
  • UCB SA
  • UniQure NV
  • United Neuroscience Ltd
  • Varinel Inc
  • Verge Genomics Inc
  • Videns Incorp Ltd
  • Vivreon Biosciences LLC
  • Voyager Therapeutics Inc
  • WhanIn Pharmaceutical Co Ltd
  • Xcelthera INC
  • Xoc Pharmaceuticals Inc
  • XYnapse Therapeutics Pty Ltd
  • Yuhan Corp
  • Yumanity Therapeutics
  • Zhittya Genesis Medicine Inc
Note: Product cover images may vary from those shown
Adroll
adroll